Novozymes’ $12.3 Billion Merger with Chr. Hansen

Simpson Thacher represented Gordon Dyal & Co. in the transaction, while Davis Polk and Plesner advised Novozymes. Kromann Reumert has advised Novo Holdings and the Novo…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now